Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study
在难治性表皮生长因子受体突变型非小细胞肺癌中，皮下注射与静脉注射阿米伐他单抗联合拉泽替尼的疗效比较：来自 III 期 PALOMA-3 研究的主要结果
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.24.01001
Leighl, Natasha B; Akamatsu, Hiroaki; Lim, Sun Min; Cheng, Ying; Minchom, Anna R; Marmarelis, Melina E; Sanborn, Rachel E; Chih-Hsin Yang, James; Liu, Baogang; John, Thomas; Massutí, Bartomeu; Spira, Alexander I; Lee, Se-Hoon; Wang, Jialei; Li, Juan; Liu, Caigang; Novello, Silvia; Kondo, Masashi; Tamiya, Motohiro; Korbenfeld, Ernesto; Moskovitz, Mor; Han, Ji-Youn; Alexander, Mariam; Joshi, Rohit; Felip, Enriqueta; Voon, Pei Jye; Danchaivijitr, Pongwut; Hsu, Ping-Chih; Silva Melo Cruz, Felipe José; Wehler, Thomas; Greillier, Laurent; Teixeira, Encarnação; Nguyen, Danny; Sabari, Joshua K; Qin, Angel; Kowalski, Dariusz; Şendur, Mehmet Ali Nahit; Xie, John; Ghosh, Debopriya; Alhadab, Ali; Haddish-Berhane, Nahor; Clemens, Pamela L; Lorenzini, Patricia; Verheijen, Remy B; Gamil, Mohamed; Bauml, Joshua M; Baig, Mahadi; Passaro, Antonio
